Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Stryker (SYK) PT Raised to $170 at Cantor Fitzgerald
-
Orchid Island Capital Announces First Quarter 2018 Results
-
Integra LifeSciences (IART) PT Raised to $59 at Cantor Fitzgerald
-
Biogen (BIIB) PT Lowered to $272 at Cantor Fitzgerald
-
Treasury yield milestone may augur changing tide for risk
-
Form 13F-HR CANTOR FITZGERALD INVEST For: Mar 31
-
Evofem Biosciences (EVFM) Plans $40M Offering of Common Stock
-
Evofem Biosciences Announces Proposed Public Offering of Common Stock
-
ProPhotonix Limited - STKR - ProPhotonix Launches New Website
-
Trilogy Metals Closes $28.7 Million Bought Deal Financing
-
Exponent (EXPO) PT Raised to $96 at Cantor Fitzgerald
-
Cantor Fitzgerald Expands into Power, Energy & Infrastructure Investment Banking with the Addition of Kevin Phillips and Hari Chandra
-
R1 RCM Inc (RCM) PT Raised to $10 at Cantor Fitzgerald
-
UPDATE: GW Pharma (GWPH) PT Raised to Street High $205 at Cantor Fitzgerald
-
Arena Pharma (ARNA) PT Raised to $65 at Cantor Fitzgerald
-
Cantor Fitzgerald & Co. Acquires Securities of Connacher Oil and Gas Limited
-
PlacementTracker Publishes Q1 2018 PIPE and Private Placement Markets League Tables
-
Denise Fiacco joins Instinet Quantitative Trading Strategy Group
-
UPDATE: Intuitive Surgical (ISRG) PT Raised to $510 at Cantor Fitzgerald
-
UnitedHealth Group (UNH) PT Raised to $300 at Cantor Fitzgerald on 1Q18 Earnings Beat; 'Strong Start to 2018'
-
Cantor Remains Positive on GW Pharma (GWPH), 'Smooth Sailing Approaching Epidiolex AdCom'
-
UPDATE: Cantor Fitzgerald Downgrades Celldex Therapeutics (CLDX) to Neutral, 'Glemba in Rear View Mirror'
-
UnitedHealth earnings ease investor worries over flu season, stock up
-
Trilogy Metals Announces US$25 Million Bought Deal Offering of Common Shares
-
Novavax Announces Closing of Public Offering
-
Novavax Announces Closing of Public Offering
-
Novavax Announces Closing of Public Offering
-
PolarityTE Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option
-
PolarityTE Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option
-
PolarityTE Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option
-
Cantor Fitzgerald Remains Bullish on Shire (SHPG) Following Announced Oncology Divestiture
-
Cantor Fitzgerald Reiterates Overweight on Horizon Pharma (HZNP)
-
Orchid Island Capital Announces April 2018 Monthly Dividend and March 31, 2018 RMBS Portfolio Characteristics
-
Cantor Remains Positive on Health Insurance Innovations (HIIQ) , Says Share Are 'Extremely Inexpensive'
-
PolarityTE (COOL) Prices 2.03M Common Stock Offering at $16/Share
-
PolarityTE Announces Pricing of Public Offering of Common Stock
-
PolarityTE Announces Pricing of Public Offering of Common Stock
-
Ur-Energy Provides 2018 Q1 Operational Results
-
UPDATE: Bellicum Pharmaceuticals (BLCM) PT Raised to $18 at Cantor Following FDA Lift of Clinical Hold on BPX-501 in US
-
Novavax (NVAX) Prices 30.3M Share Common Offering at $1.65/Sh
-
Novavax Prices Public Offering of Common Stock
-
Novavax Prices Public Offering of Common Stock
-
Novavax Prices Public Offering of Common Stock
-
PolarityTE (COOL) Reports Public Offering of Common Stock
-
PolarityTE Announces Public Offering of Common Stock
-
PolarityTE Announces Public Offering of Common Stock
-
UPDATE - Harvest Announces Executive Hires
-
Harvest Announces Executive Hires
-
ProPhotonix Honored by Vision Systems Design 2018 Innovators Awards Program
-
Tiberius Acquisition Corporation Common Stock And Warrants To Commence Trading Separately On April 10, 2018

